Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Middle East Respiratory Syndrome.

ABSTRACT:

SUBMITTER: Arabi YM

PROVIDER: S-EPMC5362064 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Middle East Respiratory Syndrome.

Arabi Yaseen M YM Balkhy Hanan H HH Hayden Frederick G FG Bouchama Abderrezak A Luke Thomas T Baillie J Kenneth JK Al-Omari Awad A Hajeer Ali H AH Senga Mikiko M Denison Mark R MR Nguyen-Van-Tam Jonathan S JS Shindo Nahoko N Bermingham Alison A Chappell James D JD Van Kerkhove Maria D MD Fowler Robert A RA

The New England journal of medicine 20170201 6

PMID: 28177862

Similar Datasets

Middle East respiratory syndrome.

Project description:Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Dromedary camels, hosts for MERS-CoV, are implicated in direct or indirect transmission to human beings, although the exact mode of transmission is unknown. The virus was first isolated from a patient who died from a severe respiratory illness in June, 2012, in Jeddah, Saudi Arabia. As of May 31, 2015, 1180 laboratory-confirmed cases (483 deaths; 40% mortality) have been reported to WHO. Both community-acquired and hospital-acquired cases have been reported with little human-to-human transmission reported in the community. Although most cases of MERS have occurred in Saudi Arabia and the United Arab Emirates, cases have been reported in Europe, the USA, and Asia in people who travelled from the Middle East or their contacts. Clinical features of MERS range from asymptomatic or mild disease to acute respiratory distress syndrome and multiorgan failure resulting in death, especially in individuals with underlying comorbidities. No specific drug treatment exists for MERS and infection prevention and control measures are crucial to prevent spread in health-care facilities. MERS-CoV continues to be an endemic, low-level public health threat. However, the virus could mutate to have increased interhuman transmissibility, increasing its pandemic potential.

| S-EPMC4721578 | biostudies-literature

Middle East respiratory syndrome.

Project description:The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34·3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.

| S-EPMC7155742 | biostudies-literature

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome-related coronavirus Genome sequencing and assembly

| PRJNA904778 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome-related coronavirus Genome sequencing and assembly

| PRJNA681678 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome-related coronavirus Genome sequencing and assembly

| PRJNA681679 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome-related coronavirus Raw sequence reads

| PRJNA376858 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:MERS Surveillance

| PRJNA292075 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome-related coronavirus Genome sequencing and assembly

| PRJNA517346 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome-related coronavirus Genome sequencing and assembly

| PRJNA1045653 | ENA

Middle East respiratory syndrome-related coronavirus

Project description:Middle East respiratory syndrome coronavirus Genome sequencing : MERS-CoV_KOR-2015

| PRJNA316178 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data